AFG
GILD icon

ABLE Financial Group’s Gilead Sciences GILD Stock Holding History

ABLE Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,034
Closed -$226K – 210
2025
Q2 		$226K Hold
2,034
– – 0.05% 189
2025
Q1 		$228K Sell
2,034
-500
-20% -$51.6K 0.06% 180
2024
Q4 		$234K Buy
+2,534
New +$228K 0.07% 174
2024
Q2 		– Sell
-9,115
Closed -$668K – 181
2024
Q1 		$668K Sell
9,115
-24
-0.3% -$1.85K 0.26% 72
2023
Q4 		$740K Buy
+9,139
New +$711K 0.32% 57
2023
Q3 		– Sell
-2,946
Closed -$227K – 148
2023
Q2 		$227K Buy
+2,946
New +$235K 0.12% 126

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ABLE Financial Group's GILD Position: Q3 2025 in Review

ABLE Financial Group sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 2,034 shares — an estimated $226K sold.

ABLE Financial Group first reported a position in GILD in Q2 2023 and held it in 6 quarters. The position peaked at $740K in Q4 2023. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • ABLE Financial Group reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • ABLE Financial Group sold 2,034 Gilead Sciences shares in Q3 2025, an estimated $226K.
  • ABLE Financial Group first reported a position in Gilead Sciences in Q2 2023 and held it in 6 quarters.
  • ABLE Financial Group's Gilead Sciences position peaked at $740K in Q4 2023.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on ABLE Financial Group's 13F filing for Q3 2025, filed 10 Oct 2025.